Physician profile
Eric D Braunstein
NPI 1952728222
$81,300.38
in general payments reported to CMS, 2019-2025
21 companies · $24K in 2025
The $24K reported for 2025 was more than what 90% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,450 · 2020: $11K · 2021: $11K · 2022: $8,993 · 2023: $3,915 · 2024: $22K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $12K · Food and Beverage: $9,805 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,780.90 |
| Travel and Lodging | $11,718.19 |
| Food and Beverage | $9,804.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,975.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $16,948.77 | 2019-2025 | Carto 3, Na |
| Boston Scientific Corporation | $16,310.89 | 2019-2025 | Ingevity+, General - Brady, General - Therapies |
| Medtronic, INC. | $13,997.94 | 2021-2025 | Evera Mri Xt Dr Surescan, Affera Mapping System, Aurora Ev-Icd Mri Surescan |
| Atricure, INC. | $11,084.29 | 2022-2024 | |
| Abbott Laboratories | $10,600.80 | 2019-2025 | Aveir, Ensite, Tendril |
| Medtronic Vascular, INC. | $6,624.94 | 2020 | |
| Biotronik INC. | $2,269.06 | 2021-2022 | |
| Altathera Pharmaceuticals LLC | $2,030.73 | 2024 | Sotalol Hydrochloride |
| Pfizer INC. | $257.15 | 2019 | |
| Lantheus Medical Imaging, INC. | $202.52 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $197.17 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.65 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $151.10 | 2019-2020 | |
| Volta Medical INC | $130.31 | 2024 | Vx1 |
| Novartis Pharmaceuticals Corporation | $118.57 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $108.01 | 2020-2021 | |
| Cordis US Corp. | $29.56 | 2024 | Mynx Venous Vcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.43 | 2019-2021 | |
| Cardiva Medical, INC. | $20.26 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.62 | 2020 | |
| Chiesi USA, INC. | $16.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Braunstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.